Akebia Therapeutics Down Over 27%, on Pace for Largest Percent Decrease Since February 2023 -- Data Talk

Dow Jones03-20

Akebia Therapeutics, Inc. (AKBA) is currently at $2.06, down $0.78 or 27.29%

--On pace for largest percent decrease since Feb. 10, 2023, when it fell 28.35%

--Snaps a four-day winning streak

--Up 11.62% month-to-date

--Up 8.68% year-to-date

--Down 92.92% from its all-time closing high of $29.17 on June 20, 2014

--Up 1.23% from 52 weeks ago (March 21, 2024), when it closed at $2.04

--Down 27.29% from its 52-week closing high of $2.84 on March 19, 2025

--Up 141.04% from its 52-week closing low of $0.86 on June 25, 2024

--Traded as low as $1.95

--Down 31.34% at today's intraday low; largest intraday percent decrease since Feb. 10, 2023, when it fell as much as 49.1%

All data as of 11:08:14 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

March 20, 2025 11:09 ET (15:09 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2520463056?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-20 23:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2520463056","market":"other","top_or_hot":-1,"title":"Akebia Therapeutics Down Over 27%, on Pace for Largest Percent Decrease Since February 2023 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  <a href=\"https://laohu8.com/S/AKBA\">Akebia Therapeutics, Inc.</a> (AKBA) is currently at $2.06, down $0.78 or 27.29% \n</p>\n<pre>\n \n</pre>\n<p>\n     --On pace for largest percent decrease since Feb. 10, 2023, when it fell 28.35% \n</p>\n<p>\n     --Snaps a four-day winning streak \n</p>\n<p>\n     --Up 11.62% month-to-date \n</p>\n<p>\n     --Up 8.68% year-to-date \n</p>\n<p>\n     --Down 92.92% from its all-time closing high of $29.17 on June 20, 2014 \n</p>\n<p>\n     --Up 1.23% from 52 weeks ago (March 21, 2024), when it closed at $2.04 \n</p>\n<p>\n     --Down 27.29% from its 52-week closing high of $2.84 on March 19, 2025 \n</p>\n<p>\n     --Up 141.04% from its 52-week closing low of $0.86 on June 25, 2024 \n</p>\n<p>\n     --Traded as low as $1.95 \n</p>\n<p>\n     --Down 31.34% at today's intraday low; largest intraday percent decrease since Feb. 10, 2023, when it fell as much as 49.1% \n</p>\n<pre>\n \n</pre>\n<p>\n     All data as of 11:08:14 AM ET \n</p>\n<pre>\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 20, 2025 11:09 ET (15:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Akebia Therapeutics Down Over 27%, on Pace for Largest Percent Decrease Since February 2023 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAkebia Therapeutics Down Over 27%, on Pace for Largest Percent Decrease Since February 2023 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-20 23:09</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  <a href=\"https://laohu8.com/S/AKBA\">Akebia Therapeutics, Inc.</a> (AKBA) is currently at $2.06, down $0.78 or 27.29% \n</p>\n<pre>\n \n</pre>\n<p>\n     --On pace for largest percent decrease since Feb. 10, 2023, when it fell 28.35% \n</p>\n<p>\n     --Snaps a four-day winning streak \n</p>\n<p>\n     --Up 11.62% month-to-date \n</p>\n<p>\n     --Up 8.68% year-to-date \n</p>\n<p>\n     --Down 92.92% from its all-time closing high of $29.17 on June 20, 2014 \n</p>\n<p>\n     --Up 1.23% from 52 weeks ago (March 21, 2024), when it closed at $2.04 \n</p>\n<p>\n     --Down 27.29% from its 52-week closing high of $2.84 on March 19, 2025 \n</p>\n<p>\n     --Up 141.04% from its 52-week closing low of $0.86 on June 25, 2024 \n</p>\n<p>\n     --Traded as low as $1.95 \n</p>\n<p>\n     --Down 31.34% at today's intraday low; largest intraday percent decrease since Feb. 10, 2023, when it fell as much as 49.1% \n</p>\n<pre>\n \n</pre>\n<p>\n     All data as of 11:08:14 AM ET \n</p>\n<pre>\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 20, 2025 11:09 ET (15:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2520463056","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2520463056","pubTimestamp":1742483340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Akebia Therapeutics, Inc.  is currently at $2.06, down $0.78 or 27.29%. --On pace for largest percent decrease since Feb. 10, 2023, when it fell 28.35%. --Down 92.92% from its all-time closing high of $29.17 on June 20, 2014. --Up 1.23% from 52 weeks ago , when it closed at $2.04. --Down 27.29% from its 52-week closing high of $2.84 on March 19, 2025. --Up 141.04% from its 52-week closing low of $0.86 on June 25, 2024. --Down 31.34% at today's intraday low; largest intraday percent decrease since Feb. 10, 2023, when it fell as much as 49.1%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","AKBA":"Akebia Therapeutics, Inc."},"translate_title":"Akebia Therapeutics股价下跌超过27%，创2023年2月以来最大跌幅——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AKBA":1},"content_text":"Akebia Therapeutics, Inc. (AKBA) is currently at $2.06, down $0.78 or 27.29% \n\n\n \n\n\n     --On pace for largest percent decrease since Feb. 10, 2023, when it fell 28.35% \n\n\n     --Snaps a four-day winning streak \n\n\n     --Up 11.62% month-to-date \n\n\n     --Up 8.68% year-to-date \n\n\n     --Down 92.92% from its all-time closing high of $29.17 on June 20, 2014 \n\n\n     --Up 1.23% from 52 weeks ago (March 21, 2024), when it closed at $2.04 \n\n\n     --Down 27.29% from its 52-week closing high of $2.84 on March 19, 2025 \n\n\n     --Up 141.04% from its 52-week closing low of $0.86 on June 25, 2024 \n\n\n     --Traded as low as $1.95 \n\n\n     --Down 31.34% at today's intraday low; largest intraday percent decrease since Feb. 10, 2023, when it fell as much as 49.1% \n\n\n \n\n\n     All data as of 11:08:14 AM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 20, 2025 11:09 ET (15:09 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2520463056"}